Skip to main content
MTEX
NASDAQ Life Sciences

Mannatech Q3 Profit Is a $10.9M Non-Cash Tax Benefit; Going Concern Doubt Persists

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Household Product Stocks · Consumer
Sentiment info
Negative
Importance info
8
Price
$8.98
Mkt Cap
$17.328M
52W Low
$3.8
52W High
$12.454
52W Position info
136% above low
Off High info
28% below high
Rel. Volume info
0.2× avg
Market data snapshot near publication time

MTEX has more than doubled off its 52-week low of $3.8 on light trading volume (0.2× avg).

Summary

Mannatech's headline Q3 profit of $8.9 million is a non-cash tax benefit; pre-tax it lost $1.95 million on sales down 14.7%, and management still flags going-concern doubt.


Key Events · Earnings and Guidance · MTEX

  • Q3 Profit Is Non-Cash Tax Benefit

    Net income of $8.9 million ($4.61 per share) includes a $10.9 million non-cash deferred tax benefit from remeasuring foreign withholding-tax liabilities; pre-tax the company lost $1.954 million.

  • Sales Decline Accelerates

    Q3 net sales fell 14.7% to $24.9 million from $29.2 million; nine-month sales were $76.4 million, down 6.1%.

  • Going Concern Doubt Persists

    Management states substantial doubt about the ability to continue as a going concern within one year continues to exist; the October 2026 Nasdaq equity cure was non-cash and did not address liquidity.

  • Cash and Operating Cash Flow

    Cash and equivalents fell to $5.4 million from $6.2 million at December 31, 2025; nine-month operating cash flow was positive $0.085 million versus negative $2.674 million a year earlier.


Analysis · MTEX · Life Sciences

The $8.9 million quarterly profit ($4.61 per share) is almost entirely an accounting entry: a $10.9 million non-cash deferred tax benefit from remeasuring foreign withholding-tax liabilities. Strip that out and Mannatech lost $1.95 million before taxes in the quarter, with sales down 14.7% to $24.9 million. Management explicitly says substantial doubt about continuing as a going concern still exists as of this report — the October restructuring that satisfied Nasdaq's $2.5 million equity rule added no cash and does not fix liquidity. Cash slipped to $5.4 million from $6.2 million at year-end. The one genuine improvement is operating cash flow, roughly breakeven at $0.1 million for nine months versus a $2.7 million burn a year ago, helped by cost cuts. Directors also extended $2.7 million of 16% insider notes to March 31, 2028, buying time but not capital.

How filings like this one have moved

In the 30 days to Nov 12, 2026, 47.3% of the 1873 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.17%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, MTEX was trading at $8.98 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $17.3M. The 52-week trading range was $3.80 to $12.45. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MTEX - Latest Insights

MTEX
Nov 12, 2026, 4:02 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $8.82
Real-time Price: $8.70 info
Change: -$0.120 (-1%) info
Market Cap: $17.328M info
MTEX
Oct 20, 2026, 5:40 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $8.26
Real-time Price: $8.70 info
Change: +$0.440 (+5%) info
Market Cap: $17.328M info
MTEX
Oct 14, 2026, 5:18 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $7.25
Real-time Price: $8.70 info
Change: +$1.45 (+20%) info
Market Cap: $17.328M info
MTEX
Aug 12, 2026, 4:03 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $5.07
Real-time Price: $8.70 info
Change: +$3.63 (+72%) info
Market Cap: $17.328M info
MTEX
Aug 12, 2026, 4:02 PM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $5.07
Real-time Price: $8.70 info
Change: +$3.63 (+72%) info
Market Cap: $17.328M info